These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25050995)

  • 41. On the importance of exposure variability to the doses of volatile organic compounds.
    Rappaport SM; Kupper LL; Lin YS
    Toxicol Sci; 2005 Feb; 83(2):224-36. PubMed ID: 15548640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monte Carlo uncertainty analysis of a diffusion model for the assessment of halogen gas exposure during dosing of brominators.
    Shade WD; Jayjock MA
    Am Ind Hyg Assoc J; 1997 Jun; 58(6):418-24. PubMed ID: 9183836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling ecological and human exposure to POPs in Venice lagoon - Part II: Quantitative uncertainty and sensitivity analysis in coupled exposure models.
    Radomyski A; Giubilato E; Ciffroy P; Critto A; Brochot C; Marcomini A
    Sci Total Environ; 2016 Nov; 569-570():1635-1649. PubMed ID: 27432731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case studies of hydrogen sulphide occupational exposure incidents in the UK.
    Jones K
    Toxicol Lett; 2014 Dec; 231(3):374-7. PubMed ID: 25111189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of long-term health risks after accidental exposure using haemoglobin adducts of epichlorohydrin.
    Wollin KM; Bader M; Müller M; Lilienblum W; Csicsaky M
    Toxicol Lett; 2014 Dec; 231(3):378-86. PubMed ID: 25072144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling aggregate exposures to glycol ethers from use of commercial floor products.
    Koontz M; Price P; Hamilton J; Daggett D; Sielken R; Bretzlaff R; Tyler T
    Int J Toxicol; 2006; 25(2):95-107. PubMed ID: 16597548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.
    Fenneteau F; Li J; Nekka F
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):495-522. PubMed ID: 19847628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
    Pelekis M; Gephart LA; Lerman SE
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing occupational and environmental exposure.
    Semple S
    Occup Med (Lond); 2005 Sep; 55(6):419-24. PubMed ID: 16140834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.
    Mörk AK; Jonsson F; Johanson G
    Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
    Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biomonitoring usage to evaluate character and severity of exposure to chemical factor].
    Med Tr Prom Ekol; 2010; (12):28-33. PubMed ID: 21442937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
    Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
    Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying a role for human biomonitoring in incidents involving hazardous materials.
    Scheepers PT; Smolders R
    Toxicol Lett; 2014 Dec; 231(3):291-4. PubMed ID: 25500134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of Bayesian population physiologically based pharmacokinetic (PBPK) modeling and Markov chain Monte Carlo simulations to pesticide kinetics studies in protected marine mammals: DDT, DDE, and DDD in harbor porpoises.
    Weijs L; Yang RS; Das K; Covaci A; Blust R
    Environ Sci Technol; 2013 May; 47(9):4365-74. PubMed ID: 23560461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moving from external exposure concentration to internal dose: duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose.
    Simmons JE; Evans MV; Boyes WK
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):927-50. PubMed ID: 16020185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamide.
    DeWoskin RS; Sweeney LM; Teeguarden JG; Sams R; Vandenberg J
    Food Chem Toxicol; 2013 Aug; 58():506-21. PubMed ID: 23707562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.